Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
LSLSL.Vthis companyLSL Pharma Group Inc	CA$0.31	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
APTX.TOApotex Health Corp.	CA$34.78	16.77×	-11.21×	1.79×	10.66×	345.4%	55.6%	22.5%	10.7%	-67.0%	17.6%	7.3%	-6.31×	3.8×	3.24×	1.5×	17.7%	—	—	—	—
CSCSCI.TOCOSCIENS Biopharma Inc.	CA$8.60	-0.21×	0.57×	0.29×	0.32×	-4514.4%	35.3%	-139.3%	-138.1%	-274.8%	-59.0%	-428.0%	0.56×	0.55×	-62.15×	3.18×	0.0%	5	0.24	2	C+
EBM.VEastwood Bio-Medical Canada Inc.	CA$1.88	-145.83×	-29.59×	61.66×	-155.88×	-105.3%	64.7%	-45.4%	-42.5%	20.4%	22.9%	0.0%	-0.05×	-0.19×	-39.38×	0.02×	0.0%	3	-6.4	1	C-
MDP.TOMedexus Pharmaceuticals Inc.	CA$5.13	-44.57×	2.06×	1.02×	9.21×	-84.1%	54.8%	5.9%	-2.4%	-4.9%	6.1%	3.7%	0.45×	1.24×	1.12×	1.19×	0.0%	5	1.26	2	C
MPH.VMedicure Inc.	CA$3.74	-1.68×	0.92×	0.41×	-2.11×	-58.2%	39.0%	-23.9%	-24.6%	-55.0%	-49.9%	-4.7%	0.07×	0.69×	0×	1.02×	0.0%	2	-1.96	3	B-
Peer median	—	-1.68×	0.57×	1.02×	0.32×	-84.1%	54.8%	-23.9%	-24.6%	-55.0%	6.1%	0.0%	0.07×	0.69×	0×	1.19×	0.0%	4	-0.86	2	—